Efficacy of anti-CD147 chimeric antigen receptors targeting hepatocellular carcinoma

Chimeric antigen receptor (CAR) therapy is a promising immunotherapeutic strategy for treating multiple refractory blood cancers, but further advances are required for solid tumor CAR therapy. One challenge is identifying a safe and effective tumor antigen. Here, we devise a strategy for targeting h...

Descripción completa

Detalles Bibliográficos
Autores principales: Tseng, Hsiang-chi, Xiong, Wei, Badeti, Saiaditya, Yang, Yan, Ma, Minh, Liu, Ting, Ramos, Carlos A., Dotti, Gianpietro, Fritzky, Luke, Jiang, Jie-gen, Yi, Qing, Guarrera, James, Zong, Wei-Xing, Liu, Chen, Liu, Dongfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511348/
https://www.ncbi.nlm.nih.gov/pubmed/32968061
http://dx.doi.org/10.1038/s41467-020-18444-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511348/
https://www.ncbi.nlm.nih.gov/pubmed/32968061
http://dx.doi.org/10.1038/s41467-020-18444-2

Ejemplares similares